Efficacy of oseltamivir treatment in influenza virus-infected obese mice
ABSTRACT Obesity has been epidemiologically and empirically linked with more severe diseases upon influenza infection. To ameliorate severe disease, treatment with antivirals, such as the neuraminidase inhibitor oseltamivir, is suggested to begin within days of infection especially in high-risk host...
Main Authors: | Rebekah Honce, Jeremy Jones, Victoria A. Meliopoulos, Brandi Livingston, Bridgett Sharp, Leonardo D. Estrada, Lindsey Wang, William Caulfield, Burgess Freeman, Elena Govorkova, Stacey Schultz-Cherry |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-08-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.00887-23 |
Similar Items
-
Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains
by: Rebekah Honce, et al.
Published: (2020-04-01) -
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
by: Chiara Medaglia, et al.
Published: (2021-06-01) -
Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution
by: Rebekah Honce, et al.
Published: (2019-05-01) -
Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
by: Parvaiz A Koul, et al.
Published: (2024-01-01) -
Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
by: Renee W. Y. Chan, et al.
Published: (2022-02-01)